triazoles has been researched along with caffeic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amore, BM; Bennett, GD; Finnell, RH; Kalhorn, TF; Lillibridge, JH; Nelson, SD; Slattery, JT | 1 |
| Boudreau, LH; Doiron, J; Picot, N; Surette, ME; Touaibia, M; Villebonet, B | 1 |
| Bender, A; De Lucia, D; Dennhardt, S; Garscha, U; Koeberle, A; Ley, SV; Listing, M; Lucio, OM; Manfredini, S; Musio, B; Rizzo, R; Werz, O | 1 |
| Cai, H; Huang, X; Huang, Y; Jiang, B; Jiang, J; Shen, H; Sun, Y; Wu, X; Xu, J; Xu, S; Yao, H; Zhang, P | 1 |
| Maruta, H; Nguyen, BCQ; Shahinozzaman, M; Takahashi, H; Tawata, S; Uto, Y | 1 |
5 other study(ies) available for triazoles and caffeic acid
| Article | Year |
|---|---|
Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
Topics: Animals; Anticonvulsants; Ascorbic Acid; Caffeic Acids; Carbamazepine; Carbon Monoxide; Catechol O-Methyltransferase; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dioxolanes; Enzyme Inhibitors; Epoxide Hydrolases; Female; Glutathione Transferase; Mice; Mice, Inbred Strains; Microsomes, Liver; NAD(P)H Dehydrogenase (Quinone); NADP; Piperonyl Butoxide; Sulfhydryl Compounds; Triazoles | 1996 |
Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.
Topics: Caffeic Acids; Cinnamates; Combinatorial Chemistry Techniques; Drug Design; Lipoxygenase Inhibitors; Molecular Structure; Structure-Activity Relationship; Triazoles | 2009 |
Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
Topics: Adult; Arachidonate 5-Lipoxygenase; Caffeic Acids; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Humans; Lipoxygenase Inhibitors; Male; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Triazoles; U937 Cells | 2015 |
Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Topics: Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Caffeic Acids; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Lipoxygenase Inhibitors; Lung Neoplasms; Molecular Structure; Structure-Activity Relationship; Triazoles | 2016 |
1,2,3-Triazolyl esterization of PAK1-blocking propolis ingredients, artepillin C (ARC) and caffeic acid (CA), for boosting their anti-cancer/anti-PAK1 activities along with cell-permeability.
Topics: A549 Cells; Animals; Anti-Infective Agents; Antineoplastic Agents; Caffeic Acids; Esters; Humans; Melanoma, Experimental; Mice; p21-Activated Kinases; Permeability; Phenylpropionates; Propolis; Solubility; Triazoles | 2017 |